Economic evaluation of psychiatric rehabilitation/self-management intervention (PPEP4All) compared with usual care in patients with Persistent Depressive Disorder (PDD) and their partner; a multicenter pragmatic randomized controlled trial.
Completed
- Conditions
- chronic depressionpersistent depressive disorder10027946
- Registration Number
- NL-OMON55681
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 179
Inclusion Criteria
chronic depression (> 2 years depressed)
Exclusion Criteria
no chronic depression, serious somatic comorbidity and/or psychiatric
comorbidity (such as psychotic or bipolar disorder)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary is quality of life (QALYs).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary are costs, psychopathology, resilience, disease burden</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie PPEP4All's impact on persistent depressive disorder (PDD) symptomatology?
How does PPEP4All psychiatric rehabilitation compare to standard-of-care interventions for chronic depression in terms of cost-effectiveness and clinical outcomes?
Are there specific biomarkers associated with treatment response to PPEP4All in patients with persistent depressive disorder (PDD)?
What are the potential adverse events and management strategies for PPEP4All psychiatric rehabilitation programs in PDD patients?
What combination approaches or competitor drugs exist for treating persistent depressive disorder (PDD) alongside psychiatric rehabilitation interventions like PPEP4All?